Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004379

Chief Executive Officer sold 10,057 shares at $1.86 ($18,686)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Rawcliffe Adrian Chief Executive Officer 2023-01-17 Sale −10,057 $1.86 $18,686 13,351 D
Open-market sales · 10,057 sh · avg $1.86 · $18,686
Loading xslF345X03/tm231655-17_4seq1.xml…